Medical societies join ACR to oppose policy limiting access to in-office treatments

(American College of Rheumatology) Providers are concerned the mandate adds an additional layer of red tape that will delay patient care, reduce the ability of providers to ensure therapies have been properly handled and safely stored, inflate patient out-of-pocket costs, and result in an increase of drug waste.